Location: Home
  • search
  • go
  • News
  • 7/2/2025API China 2025 Ends with High Attendance and Global Industry Participa...
  • 7/2/2025China to Eliminate CD Submission Requirement for Clinical Trial Databa...
  • 7/2/2025China Issues Technical Guidance for Clinical Resistance Studies of Ant...
  • 7/2/2025HanchorBio and Henlius Ink Major Licensing Deal for I/O Candidate HCB1...
  • 7/2/2025InventisBio Launches First Phase III Trial of TYK2 Inhibitor D‑2570 i...
  • 7/2/2025Betta's Tibremciclib Approved in China for Advanced HR+/HER2– Breast ...
  • 7/2/2025NMPA Grants Marketing Approval to GeneScience's Firsekibart for Acute ...
  • 7/2/2025China Grants Conditional Approval to Bebetter Medicine's Ifupinostat f...
  • 7/2/2025Simcere's Suvemcitug Approved in China for Platinum-Resistant Ovarian ...
  • 7/2/2025Biokin's Iza-bren Achieves Primary Endpoint in Phase III Trial for Nas...
  • 7/1/2025Record China Pharma Monopoly Fine Sends Strong Deterrent Signal, Exper...
  • 7/1/2025Jinhua Conba and EVA Forge Strategic Partnership to Strengthen China-M...
  • 7/1/2025China's STAR Market Approves Heyuan Biotech's IPO
  • 7/1/2025China Launches New Tax Incentives to Boost Foreign Companies' Reinvest...
  • 7/1/2025​​​​​​​Zai Lab-Backed FORTITUDE-101 Trial Hits Key Milestone in...
  • 7/1/2025Revolution Medicines and Summit Therapeutics Launch RAS-Targeting Comb...
  • 7/1/2025Hengrui's Ivarmacitinib Approved in China for Severe Alopecia Areata
  • 7/1/2025Adagene Secures Up to $25 Million from Sanofi to Advance SAFEbody Pipe...
  • 7/1/2025Healthgen Biotech IPO Approved, First STAR Market Biopharma Case Since...
  • 7/1/2025NHSA Seeks Public Input on 2025 Drug Reimbursement and Innovation List...
  • 7/1/2025CDE Seeks Feedback on Draft Guidelines for Pharma Changes in Cell Ther...
  • 7/1/2025Biological E and China's Recbio Partner to Bring HPV9 Vaccine to India...
  • 7/1/2025Hutchmed Receives Chinese Approval for Lung Cancer Drug Combo, Trigger...
  • 7/1/2025Mabwell Announces License Deal with Qilu for Albipagrastim alfa for I...
  • 6/30/2025CDE Reopens Public Consultation on Revised Technical Guidelines for Co...
  • 6/30/2025China's Draft National Medical Security Law: Seven Key Highlights Sign...
  • 6/30/2025China's Pharma Market Faces Mixed Performance in Q1 2025 Amid Shifting...
  • 6/30/2025China Medical System to Pursue Secondary Listing on Singapore Exchange
  • 6/30/2025GenFleet IPO Highlights Promising RAS-Targeted Drug Pipeline
  • 6/30/2025QL Biopharma's Dual GLP‑1/FGF21 Agonist ZT‑003 Gains IND Nod in U.S....
  • Page:1/53 Total number of articles:1564: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group